Edmond De Rothschild Holding S.A. Bristol Myers Squibb CO Transaction History

Edmond De Rothschild Holding S.A.

$5.7 Billion
Q4 2024

A detailed history of Edmond De Rothschild Holding S.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 266,859 shares of BMY stock, worth $14.4 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

266,859

Previous 237,261 12.47%

Holding current value

$14.4 Million

Previous $12.3 Million 22.93%

% of portfolio

0.26%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$51.92 - $59.94 $1.54 Million - $1.77 Million	29,598 Added 12.47%	266,859 $15.1 Million
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $405,126 - $528,626	-10,215 Reduced 4.13%	237,261 $12.3 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $6.63 Million - $8.73 Million	-164,753 Reduced 39.97%	247,476 $10.3 Million
Q1 2024 May 08, 2024	SELL	$47.98 - $54.4 $1.9 Million - $2.16 Million	-39,638 Reduced 8.77%	412,229 $22.4 Million
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $767,050 - $915,302	15,822 Added 3.63%	451,867 $23.2 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $2.86 Million - $3.19 Million	49,318 Added 12.75%	436,045 $25.3 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $1.98 Million - $2.2 Million	-31,136 Reduced 7.45%	386,727 $24.7 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $20,830 - $23,626	317 Added 0.08%	417,863 $29 Million
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $1.09 Million - $1.29 Million	-15,882 Reduced 3.66%	417,546 $30 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $2,527 - $1.49 Million	19,441 Added 4.7%	433,428 $30.8 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $3.65 Million - $4.02 Million	-50,201 Reduced 10.81%	413,987 $31.9 Million
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $422,183 - $506,235	-6,867 Reduced 1.46%	464,188 $33.9 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $1.02 Million - $1.19 Million	-19,112 Reduced 3.9%	471,055 $29.4 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $1.68 Million - $1.97 Million	28,372 Added 6.14%	490,167 $29 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $1.67 Million - $1.82 Million	27,043 Added 6.22%	461,795 $30.9 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $1.34 Million - $1.51 Million	22,634 Added 5.49%	434,752 $27.4 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $1.84 Million - $2.09 Million	31,925 Added 8.4%	412,118 $25.6 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $4.46 Million - $4.95 Million	77,712 Added 25.69%	380,193 $22.9 Million
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $1.18 Million - $1.38 Million	-21,554 Reduced 6.65%	302,481 $17.8 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $806,060 - $1.17 Million	17,372 Added 5.66%	324,035 $18.1 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $7.11 Million - $9.28 Million	144,549 Added 89.17%	306,663 $19.7 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $1.29 Million - $1.53 Million	30,232 Added 22.92%	162,114 $8.22 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $858,354 - $949,153	19,237 Added 17.08%	131,882 $5.98 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $63,388 - $82,199	-1,300 Reduced 1.14%	112,645 $5.86 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $22,903 - $25,833	-415 Reduced 0.36%	113,945 $7.07 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $838,798 - $1.05 Million	-16,600 Reduced 12.68%	114,360 $6.33 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $44,640 - $51,390	745 Added 0.57%	130,960 $8.28 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $4.09 Million - $4.46 Million	-68,200 Reduced 34.37%	130,215 $7.98 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $11 Million - $12.6 Million	198,415	198,415 $12.6 Million

Others Institutions Holding BMY

# of Institutions

2,729

Shares Held

1.57B

Call Options Held

30M

Put Options Held

31.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Account

Edmond De Rothschild Holding S.A. Bristol Myers Squibb CO Transaction History